Clinical Trial Update: A Proof of Concept Study of the Safety, Tolerability, and Efficacy of Avastin (Bevacizumab) in Patients With Chemo-naive Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial evaluating Avastin (bevacizumab) for safety, tolerability, and efficacy in chemo-naive chronic lymphocytic leukemia; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2014-06-26